Bristol-Meyers, Pfizer Hid Eliquis Risks, $10M Suit Alleges
Bristol-Myers Squibb and Pfizer Inc. have failed to disclose that their blockbuster blood thinner Eliquis has been linked to life-threatening conditions, including excessive bleeding, in a disregard for patient safety, according...To view the full article, register now.
Already a subscriber? Click here to view full article